How much revenue does Notable Labs make?

Notable Labs reported $310,000 in revenue for fiscal year 2023, up 3775.0% from $8,000 in fiscal year 2022. In Q2 2024 revenue was $2,000.

What companies are similar to Notable Labs?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Immunotech Laboratories, Inc. (IMMB), ContraFect Corporation (CFRXQ), Eureka 93 Inc. (LXLLF), Cardax, Inc. (CDXI).

Notable Labs, Ltd. (NTBLQ) Stock

About Notable Labs, Ltd.

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive medicines for patients with cancer. The company, through its proprietary Predictive Medicines Platform (PMP), bio-simulates a patient's cancer treatment and predicts whether patient will clinically respond to their actual treatment. Its PMP is designed to identify and select patients expected to be clinically r...

At a glance

Notable Labs reported revenue of $310,000 for fiscal year 2023, up 3775.0% from fiscal year 2022, and net income of -$11.26 million. In Q2 2024 (the quarter ended June 30, 2024) revenue was $2,000.

Figures from company filings; latest fiscal year ended December 31, 2023.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.